StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report report published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.
About Calithera Biosciences
Further Reading
- Five stocks we like better than Calithera Biosciences
- Trading Stocks: RSI and Why it’s Useful
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- What Are Dividend Achievers? An Introduction
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- 3 Small Caps With Big Return Potential
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
